A detailed look at the Wakefit Innovations and Corona Remedies IPOs, examining subscription status, pricing, potential gains, and expert opinions to help investors evaluate which offering stands out.

Corona Remedies’ IPO is scheduled to debut on the stock exchanges today, December 15, following strong investor demand during ...

As per the latest update, the company’s shares are trading at Rs 1,353 in the unlisted markets. This indicates a premium of nearly 28% over the upper price band. The company has fixed the price band ...

Corona Remedies Share Price, IPO Listing, GMP Live Updates: Corona Remedies is all set to hit the secondary market, after the ...

Corona Remedies’ shares made a strong debut on the stock market, gaining 36.72 per cent over its IPO price. The pharma ...

The Rs 655.37-crore initial public offering (IPO) of Crorona Remedies mobilised Rs 195 crore from anchor investors.

Investor participation was enthusiastic across all categories. Overall, the issue was subscribed to 144.5 times, driven ...

Corona Remedies and Wakefit Innovations are set to list amid divergent grey market signals. Corona Remedies commands strong ...

The COVID-19 cases have been increasing in India and across Asia. In the last couple of weeks, Hong Kong and Singapore have recorded a significant number of cases. "The virus is quite active," said ...

At a price band of Rs 1,008–1,062 per share and a lot size of 120 shares, the Rs 655.37-crore IPO triggered massive interest, drawing 62.65 crore bids against just 45.72 lakh shares available, based ...

CORONA REMEDIES LTD.: Get the latest CORONA REMEDIES LTD. Share price and stock price updates, live NSE/BSE share price, share market reports, financial report, balance sheet, price charts, financial ...